OptiLight IPL (Lumenis)
FDA-cleared intense pulsed light treatment for meibomian gland dysfunction. Reduces inflammation and stimulates gland function. Series of 4 sessions, 15 min each, three weeks apart.
Dry eye disease is the most under-treated condition in optometry. Our standalone clinic combines IPL, LipiFlow, prescription drops, and a 90-day at-home protocol. 78% of patients report measurable improvement at week 12.
The OSDI is a validated dry-eye screening tool used by ophthalmology and optometry worldwide. Score it now, and we'll route you to the right next step. No email needed to see your result.
An hour-long evaluation maps your meibomian glands, measures tear film thickness, and quantifies your OSDI score. We pinpoint whether your dry eye is evaporative (gland dysfunction), aqueous (low tear volume), or mixed.
Most patients combine in-office IPL or LipiFlow (4 sessions) with an at-home routine: warm compresses, lid hygiene, omega-3, and prescription drops if indicated (Restasis, Xiidra, Cequa, Tyrvaya).
At week 12 we re-image your meibomian glands and re-score your OSDI. 78% of patients see measurable improvement (≥30% OSDI reduction). We taper your protocol to maintenance · usually a quick at-home routine and an annual touch-up IPL.
Most optometry offices in NY refer dry eye to ophthalmology. We carry both core devices ourselves, so you can stay in one clinic from diagnosis through maintenance.
FDA-cleared intense pulsed light treatment for meibomian gland dysfunction. Reduces inflammation and stimulates gland function. Series of 4 sessions, 15 min each, three weeks apart.
Thermal pulsation that liquefies and clears blocked meibomian gland obstructions. Single 12-minute treatment, lasts 12-18 months. Ideal for patients with severe gland blockage who can't tolerate IPL.
Book a diagnostic evaluation · we'll measure, plan, and start treatment the same week. Most insurance covers the diagnostic visit when symptoms are documented.